Company: BGHL
Filing Date: 2025-07-07
Form Type: DRS/A
Source: 0001213900-25-061617
Chunk: 10

Company: BILLION GROUP HOLDINGS Ltd
Filing Date: 2025-07-07
Form: DRS/A
Chunk 10
---
 is truthful or complete. Any representation to the contrary is a criminal offense. Investing in our Ordinary Shares involves a high degree of risk, including the risk of losing your entire investment. See “Risk Factors” beginning on page 13 of this prospectus to read about factors you should consider before buying our Ordinary Shares.

|                                           |     | PER SHARE |     | TOTAL |     |
|:------------------------------------------|:----|:----------|:----|:------|:----|
| Initial public offering price(1)          |     | $         |     | $     | [*] |
| Underwriting discounts and commissions(2) |     | $         |     | $     | [*] |
| Proceeds, before expenses, to us(3)       |     | $         |     | $     | [*] |

____________ (1) Assumes that the underwriters do not exercise their over -allotment option. For more information, see “Underwriting” in this prospectus. (2) We have agreed to pay the underwriters a discount equal to seven percent (7.0%) of the gross proceeds of this offering. We have also agreed to pay the representative of the underwriters, American Trust Investment Services, Inc. (“ATIS” or the “Representative”), a non -accountable expense allowance equal to one percent (1.0%) of the gross proceeds raised and to reimburse the underwriters for certain expenses incurred relating to this offering. These payments will further reduce proceeds available to us before expenses. For a description of compensation and other items of value payable to the underwriters, see “Underwriting” beginning on page 104. (3)We expect our total cash expenses payable by us for this offering, excluding the underwriting discount and other fees and expenses payable to the underwriters, to be approximately $[*]. These payments will further reduce proceeds available to us before expenses. See “Underwriting.” This Offering is being conducted on a firm commitment basis. The underwriters are obligated to take and pay for all of the Ordinary Shares if any such Ordinary Shares are taken. We have granted the underwriters an option for a period of thirty (30) days after the closing of this Offering to purchase up to 15% of the total number of our Ordinary Shares to be offered by us pursuant to this Offering (excluding shares subject to this option), solely for the purpose of covering over -allotments, at the initial public offering price less the underwriting discounts and commissions. If the under